Business Wire

The newsfeed available here is provided by our content partner Business Wire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public. Business Wire is a subsidiary of the Warren Buffett Group Berkshire Hathaway.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
System-State: Number of processed items 23.294 Notifications successully processed since Inception
Business Wire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
US68752M1080
State: 16.01.2025 | 6AM
Do you already know our new terminal view? Click here.
FIGI: BBG000G1C210
OFIX
Orthofix Medical Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Medical Devices
NAME
Orthofix Medical Inc.
ISIN
US68752M1080
TICKER
OFIX
MIC
XNAS
REUTERS
OFIX.OQ
BLOOMBERG
OFIX US
Tue, 12.11.2024       Orthofix Medical
US68752M1080

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences: Stifel 2024 Healthcare Conference in New York, NY, November 18, 2024, fireside chat a...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Thu, 07.11.2024       Orthofix Medical
US68752M1080

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the entry into a new credit agreement providing the Company with up to $275 million in a senior-secured term loan with a 48-month interest only period. The term loan is agented by Oxford Finance LLC (“Oxford”) and provides non-dilutive capital and fin...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Thu, 07.11.2024       Orthofix Medical
US68752M1080

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2024, reiterated its full-year 2024 financial guidance, and introduced new three-year financial targets. Recent Highlights Third quarter 2024 net sales of $196.6 million, an increase of...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 21.10.2024       Orthofix Medical
US68752M1080

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) and reminds investors of the October 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruq...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 21.10.2024       Orthofix Medical
US68752M1080

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. ...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 21.10.2024       Orthofix Medical
US68752M1080

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Stifel 2024 Healthcare Conference in New York. Management is scheduled to present on Monday, November 18, 2024 at 8:35 am ET. Interested parties can access the live and archived webcast of the presentation in ...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Fri, 18.10.2024       Orthofix Medical
US68752M1080

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc. (NasdaqGS: OFIX), if they purchased the Company’s shares between October 1...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Thu, 17.10.2024       Orthofix Medical
US68752M1080

The Law Offices of Frank R. Cruz reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, inclusive (the “Class Period”). ...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Thu, 10.10.2024       Orthofix Medical
US68752M1080

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2024 financial results on Thursday, November 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 am ET the same day. Interested parties may access the confer...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 23.09.2024       Orthofix Medical
US68752M1080

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) and certain current and former officers and directors of Orthofix and SeaSpine Holdings Corporation ("SeaSpine"). Cl...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 23.09.2024       Orthofix Medical
US68752M1080

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the presentation of new data supporting the use of Orthofix’s proprietary Pulsed Electromagnetic Field (PEMF) stimulation to increase fusion rates as an adjunct to lumbar spine fusion surgery. Patients treated with the SpinalStim™ bone growth therapy ...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Tue, 17.09.2024       Orthofix Medical
US68752M1080

Robbins LLP reminds investors that a shareholder filed a class action on behalf of former SeaSpine Holdings Corporation shareholders that purchased or otherwise acquired newly issued Orthofix Medical Inc. (NASDAQ: OFIX) stock in exchange for SeaSpine shares pursuant to the January 5, 2023 stock-for-stock transaction by which Orthofix merged with a...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Sun, 15.09.2024       Orthofix Medical
US68752M1080

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) and certain current and former officers and directors of Orthofix and SeaSpine Holdings Corporation ("SeaSpine"). Cl...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Thu, 05.09.2024       Orthofix Medical
US68752M1080

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (NASDAQ: OFIX) stock between October 11, 2022 and September 12, 2023. Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone growth therapies...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Wed, 04.09.2024       Orthofix Medical
US68752M1080

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleg...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Fri, 30.08.2024       Orthofix Medical
US68752M1080

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of those who acquired Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) securities during the period of October 11, 2022 through September 12, 2023, inclusive (“the Class ...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Tue, 27.08.2024       Orthofix Medical
US68752M1080

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleg...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Tue, 27.08.2024       Orthofix Medical
US68752M1080

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (NASDAQ: OFIX) stock between October 11, 2022 and September 12, 2023. Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone growth therapies...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 26.08.2024       Orthofix Medical
US68752M1080

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, inc...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink
Mon, 26.08.2024       Orthofix Medical
US68752M1080

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, inclusive (the “Class Period”). Orthofix investors have until O...
Read More
Orthofix Medical
Technical Analysis Termsheet Terminal
Permalink

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.